Clarenta Group Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
350
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
2
Clarenta Group General Information
Description
Provider of clinical research services intended to support the development of medical treatments. The company offers clinical trial services, phase I research, regulatory services, data management services, biostatistics services and functional service provider solutions, enabling pharmaceutical and biotechnology firms to manage clinical trials from phase I to IV.
Contact Information
Website
www.clarenta.comCorporate Office
- 69, Bulgaria Boulevard Floor 7
- Tower (Building) B
- Sofia, 1404
- Bulgaria
Corporate Office
- 69, Bulgaria Boulevard Floor 7
- Tower (Building) B
- Sofia, 1404
- Bulgaria
Clarenta Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Clarenta Group Patents
Clarenta Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3370607-A1 | Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway | Inactive | 20-Nov-2015 | ||
| GB-201520496-D0 | Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway | Inactive | 20-Nov-2015 | ||
| GB-2544541-A | Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway | Inactive | 20-Nov-2015 | ||
| US-20180325421-A1 | Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway | Inactive | 20-Nov-2015 | ||
| WO-2017085165-A1 | Method and device for measurement of exhaled respiratory gas temperature from specific regions of the airway | Inactive | 20-Nov-2015 | A61B5/01 |
Clarenta Group Signals
Clarenta Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Clarenta Group Investments (2)
Clarenta Group’s most recent deal was a Buyout/LBO with Leads To Development. The deal was made on 30-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Leads To Development | 30-Sep-2026 | Buyout/LBO | Other Healthcare Services | ||
| Ilife Consulting | 22-May-2025 | Buyout/LBO | Consulting Services (B2B) |
Clarenta Group Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ilife Consulting | Paris, France | 2013 | |
| Leads To Development | Paris, France | 2009 |
Clarenta Group FAQs
-
When was Clarenta Group founded?
Clarenta Group was founded in 1997.
-
Where is Clarenta Group headquartered?
Clarenta Group is headquartered in Sofia, Bulgaria.
-
What is the size of Clarenta Group?
Clarenta Group has 350 total employees.
-
What industry is Clarenta Group in?
Clarenta Group’s primary industry is BPO/Outsource Services.
-
Is Clarenta Group a private or public company?
Clarenta Group is a Private company.
-
What is Clarenta Group’s current revenue?
The current revenue for Clarenta Group is .
-
Who are Clarenta Group’s investors?
EdgeCap Partners has invested in Clarenta Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process